摘要
核黄素或维生素B2,在细胞中作为FAD和FMN生物前体有重要作用,为黄素蛋白的结构和功能必不可少的两个重要的黄素辅因子。核黄素已应用于先天性代谢的各种治疗方法,尤其是在代谢紊乱导致的无论是从参与了核黄素代谢和运输或缺陷在黄素酶蛋白缺陷。本次总结的范围是提供一个更新的角度来看,在临床情况下,使用的是作为一个潜在的治疗剂在影响线粒体能量代谢紊乱的临床情况下。特别是,我们讨论了解核黄素作为错误折叠的代谢黄素酶复苏药物分子伴侣的作用的机理。
关键词: 核黄素反应性,黄素酶,核黄素转运、代谢紊乱,线粒体β氧化障碍,呼吸链缺陷
Current Drug Targets
Title:Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders
Volume: 17 Issue: 13
Author(s): Bárbara J. Henriques, Tânia G. Lucas, Cláudio M. Gomes
Affiliation:
关键词: 核黄素反应性,黄素酶,核黄素转运、代谢紊乱,线粒体β氧化障碍,呼吸链缺陷
摘要: Riboflavin, or vitamin B2, plays an important role in the cell as biological precursor of FAD and FMN, two important flavin cofactors which are essential for the structure and function of flavoproteins. Riboflavin has been used in therapeutic approaches of various inborn errors of metabolism, notably in metabolic disorders resulting either from defects in proteins involved in riboflavin metabolism and transport or from defects in flavoenzymes. The scope of this review is to provide an updated perspective of clinical cases in which riboflavin was used as a potential therapeutic agent in disorders affecting mitochondrial energy metabolism. In particular, we discuss available mechanistic insights on the role of riboflavin as a pharmacological chaperone for the recovery of misfolded metabolic flavoenzymes.
Export Options
About this article
Cite this article as:
Bárbara J. Henriques, Tânia G. Lucas, Cláudio M. Gomes , Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666160813180812
DOI https://dx.doi.org/10.2174/1389450117666160813180812 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Self-Regulatory Control and Habit Learning in the Development of Eating Disorders
Current Psychiatry Reviews Employing New Cellular Therapeutic Targets for Alzheimers Disease: A Change for the Better?
Current Neurovascular Research TrkB Receptor Agonist 7, 8 Dihydroxyflavone Triggers Profound Gender- Dependent Neuroprotection in Mice After Perinatal Hypoxia and Ischemia
CNS & Neurological Disorders - Drug Targets <i>In-silico</i> Identification and Analysis of Hub Proteins for Designing Novel First-line Anti-seizure Medications
Letters in Drug Design & Discovery Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Current Pharmaceutical Design Valproic Acid in the Complex Therapy of Malignant Tumors
Current Drug Targets Recent Advances in the Synthesis of New Antimycobacterial Agents Based on the 1H-1,2,3-Triazoles
Current Topics in Medicinal Chemistry Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Current Drug Safety <i>Thespesia populnea</i>: An Ethnomedicinal, Phytochemical and Pharmacological Review
The Natural Products Journal Development of 1, 3 Benzothiazol-2-yl Hydrazine Derivatives Containing Semicarbazone and Thioamide Pharmacophore as Anticonvulsants
Letters in Drug Design & Discovery Perspectives on Phytochemicals as Antibacterial Agents: An Outstanding Contribution to Modern Therapeutics
Mini-Reviews in Medicinal Chemistry Editorial Review 2015
Current Radiopharmaceuticals Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Global Trends in Nanotechnological Approaches for Various Health Issues – Volume II)
Current Drug Metabolism Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction
Current Drug Targets Editorial [Hot Topic: Drugs and Pregnancy (Guest Editor: Zaneta Kimber-Trojnar)]
Current Pharmaceutical Biotechnology Preface
Current Drug Targets - CNS & Neurological Disorders Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis
Current Pharmaceutical Design A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors
Letters in Drug Design & Discovery Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design